IL17A and inflammatory bowel disease: The IL-23/IL-17 axis has been implicated in several rodent models of disease (rheumatoid arthritis, inflammatory bowel disease, spondylarthritis, experimental autoimmune encephalitis, asthma) [24, 27, 34–37].